proflavine has been researched along with Prostatic Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dostal, V; Fanta, D; Reiss-Gutfreund, RJ | 1 |
| Adelstein, SJ; Fayad, F; Kassis, AI; Kinsey, BM; Venkateshan, CN | 1 |
1 review(s) available for proflavine and Prostatic Neoplasms
| Article | Year |
|---|---|
[Herpes simplex virus (hsv-1 and hsv-2) infection: its clinical and oncogenic properties (author's transl)].
Topics: Amantadine; Animals; Antibody Formation; Antigen-Antibody Complex; BCG Vaccine; Cell Transformation, Neoplastic; Complement C3; Cytarabine; DNA, Viral; Female; Ganglia; Genital Diseases, Female; Genital Diseases, Male; Haplorhini; Herpes Labialis; Herpes Simplex; Herpesvirus 4, Human; Humans; Idoxuridine; Immunity, Cellular; Levamisole; Male; Proflavine; Prostatic Neoplasms; Rabbits; Uterine Cervical Neoplasms; Vidarabine; Viral Vaccines | 1977 |
1 other study(ies) available for proflavine and Prostatic Neoplasms
| Article | Year |
|---|---|
Synthesis and biological activity of the intercalating agent 3-acetamido-5-[123/125I]iodo-6-aminoacridine.
Topics: Acridines; DNA; Humans; In Vitro Techniques; Intercalating Agents; Iodine Radioisotopes; Isotope Labeling; Male; Proflavine; Prostatic Neoplasms | 1990 |